Cleveland Biolabs (CBLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBLI | CKPT | GNTA | ||
| Company | Cleveland Biolabs | Checkpoint Therapeutics Inc | Genenta Science S.P.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.44 | 1.4200 | 2.90 | ||
| High | 3.52 | 1.4600 | 2.95 | ||
| Low | 3.11 | 1.3900 | 2.49 | ||
| Last | 3.17 | 1.4300 | 2.59 | ||
| Change | -0.25 | +0.0100 | -0.32 | ||
| % Change | -7.31% | +0.70% | -11.12% | ||
| Volume | 116,400 | 541,800 | 11,100 | ||
| 20-Day Average Volume | 124,330 | 361,995 | 7,365 | ||
| Previous Close | 3.42 | 1.4200 | 2.91 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.39 | 1.6957 | 3.36 | ||
| 20-Day Raw Stochastic | 36.43% | 5.80% | 22.06% | ||
| 20-Day Relative Strength | 41.15% | 29.88% | 37.54% | ||
| Weighted Alpha | -0.71 | -41.72 | -62.37 | ||
| Today's Opinion | 88% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 72% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 72% Sell | 64% Sell | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.12% since 08/24/21 | -2.05% since 04/19/24 | -33.61% since 04/19/24 | ||
| Low | 3.11 on 08/31/21 | 1.3900 on 04/26/24 | 2.20 on 04/24/24 | ||
| High | 3.55 on 08/27/21 | 1.5400 on 04/22/24 | 3.97 on 04/22/24 | ||
| 1-Month | |||||
| %Chg | -26.28% since 07/30/21 | -30.92% since 03/26/24 | -31.77% since 03/26/24 | ||
| Low | 2.70 on 08/16/21 | 1.3900 on 04/26/24 | 2.20 on 04/24/24 | ||
| High | 4.23 on 08/02/21 | 2.1000 on 03/28/24 | 3.97 on 04/22/24 | ||
| 3-Month | |||||
| %Chg | -41.30% since 05/28/21 | -14.88% since 01/26/24 | -36.05% since 01/26/24 | ||
| Low | 2.70 on 08/16/21 | 1.3900 on 04/26/24 | 2.20 on 04/24/24 | ||
| High | 7.10 on 07/06/21 | 2.3550 on 03/06/24 | 4.90 on 02/20/24 | ||
| 6-Month | |||||
| %Chg | -45.25% since 02/26/21 | -28.14% since 10/26/23 | -52.15% since 10/26/23 | ||
| Low | 2.70 on 08/16/21 | 1.3600 on 12/18/23 | 2.20 on 04/24/24 | ||
| High | 7.17 on 04/13/21 | 3.6200 on 12/07/23 | 5.50 on 11/20/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 49,068 | 51,031 | 47,182 | ||
| Shares Outstanding, K | 15,479 | 35,686 | 18,217 | ||
| Annual Sales | 260,000 | 100,000 | 0 | ||
| Annual Net Income | -2,400,000 | -51,850,000 | -12,600,000 | ||
| Last Quarter Sales | 0 | 10,000 | N/A | ||
| Last Quarter Net Income | -660,000 | -19,130,000 | N/A | ||
| 60-Month Beta | 0.70 | 0.99 | 0.72 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.10 on 03/22/24 | N/A | ||
| Latest Earnings Date | 08/16/21 | 05/20/24 | 04/24/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||